This weekend, I'm sitting in an MBA course focused on drug and device regulations. You won't find a course like this is many other MBA programs, but I'm enrolled in a program that focuses on the pharmaceutical and health care industry. It's great to be surrounded by other colleagues who understand the issues that impact a rapidly evolving industry. Here's a brief description of the course:
With the plethora of new communications vehicles, including direct-to-consumer advertising and the Internet, the goal of achieving marketing objectives and remaining in adherence with FDA regulations/ guidelines has become increasingly difficult. This course will provide a working knowledge of the federal regulation of prescription drug promotion and associated marketing practices and will provide insight into drug promotion issues currently of interest to FDA and the pharmaceutical industry. The course will also consider the impact of products liability and anti-kickback concerns on developing marketing programs for prescription drugs.
About my Business School Blog:
I am currently a business school student in the Pharmaceutical and Healthcare Executive MBA program at Saint Joseph's University Erivan K. Haub School of Business in Philadelphia, PA. The Nationally-ranked and AACSB-accredited Haub School of Business, centrally located in the mid-Atlantic pharmaceutical and healthcare corridor, is able to bring together industry experts and a world-class faculty for a unique industry-focused, immersive executive program.
You can read about my business school experience by reading all the blog posts tagged "Business School Blog."